Skip to content
OpenCapital
Get started

Innovate VATE Payments To Noncontrolling Interest Related To Former Sale Of Equity Method Investments

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept vate:PaymentsToNoncontrollingInterestRelatedToFormerSaleOfEquityMethodInvestments.

The official record: Innovate’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Innovate's payments to noncontrolling interest related to former sale of equity method investments?
Innovate (VATE) reported payments to noncontrolling interest related to former sale of equity method investments of $0 in Q4 2025.
How has Innovate's payments to noncontrolling interest related to former sale of equity method investments changed year-over-year?
Innovate's payments to noncontrolling interest related to former sale of equity method investments decreased by 100.0% year-over-year, from $75K to $0.
What does payments to noncontrolling interest related to former sale of equity method investments mean?
Tracks cash outflows made to noncontrolling interest holders specifically tied to the historical sale of equity method investments. This metric is essential for understanding how divestment proceeds are shared with minority partners.